PAVmed Inc. SEC filings PAVM

PAVmed Inc. has 691 filings in SEC EDGAR's recent list, going back to Nov 19, 2014. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (material agreement, change to shareholder rights). The company's fiscal year ends on December 31.

PAVmed Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 23, 2026 —
8-K Current report
Material agreement, Change to shareholder rights
Oct 22, 2026 Oct 21, 2026
8-K Current report
Material agreement
Sep 10, 2026 Sep 9, 2026
424B5 Prospectus supplement Sep 10, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2026 Aug 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
S-8 Employee stock plan registration Jul 30, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 24, 2026 Jun 24, 2026
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
May 15, 2026 May 15, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
SCHEDULE 13G Ownership over 5% (passive) May 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 11, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Apr 30, 2026
DEFA14A Additional proxy material Apr 30, 2026 —
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
EFFECT Filing Apr 29, 2026 —
424B3 Prospectus Apr 29, 2026 —
CORRESP Letter to the SEC Apr 27, 2026 —
UPLOAD Letter from the SEC Apr 24, 2026 —
S-3 Shelf registration Apr 21, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 14, 2026 —
4 Insider transaction Apr 13, 2026 Apr 2, 2026
3 Initial insider ownership Apr 13, 2026 Mar 24, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 13, 2026 —
SCHEDULE 13D Ownership over 5% (active) Apr 9, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 8, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 8, 2026 —
3 Initial insider ownership Apr 6, 2026 Mar 27, 2026
4 Insider transaction Apr 3, 2026 Apr 2, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 3, 2026 —
4 Insider transaction Apr 3, 2026 Apr 2, 2026
4 Insider transaction Apr 3, 2026 Apr 2, 2026
4 Insider transaction Apr 3, 2026 Apr 2, 2026
4 Insider transaction Apr 3, 2026 Apr 2, 2026
4 Insider transaction Apr 3, 2026 Apr 2, 2026
4 Insider transaction Apr 3, 2026 Apr 2, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 3, 2026 —
4 Insider transaction Apr 3, 2026 Apr 2, 2026
4 Insider transaction Apr 3, 2026 Apr 2, 2026
S-8 Employee stock plan registration Apr 2, 2026 —
S-8 Employee stock plan registration Apr 2, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Mar 30, 2026 Mar 30, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Mar 27, 2026 Mar 27, 2026
10-K Annual report Mar 27, 2026 Dec 31, 2025
DEF 14A Proxy statement Feb 24, 2026 Feb 24, 2026
D Filing Feb 17, 2026 —
PRE 14A Preliminary proxy statement Feb 13, 2026 Feb 13, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 9, 2026 —
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Feb 4, 2026 Feb 3, 2026
8-K Current report
Other events
Jan 23, 2026 Jan 21, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Dec 30, 2025 Dec 30, 2025
8-K Current report
Shareholder vote results
Dec 5, 2025 Dec 5, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2025 Nov 13, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
DEF 14A Proxy statement Oct 31, 2025 Oct 31, 2025
PRE 14A Preliminary proxy statement Oct 20, 2025 Oct 20, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 10, 2025 —
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
8-K Current report
Other events
Sep 11, 2025 Sep 11, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2025 Aug 14, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Other events
Jul 30, 2025 Jul 29, 2025
S-8 Employee stock plan registration Jul 28, 2025 —
8-K Current report
Material agreement
Jun 24, 2025 Jun 23, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 18, 2025 Jun 18, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
May 15, 2025 May 15, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
DEFA14A Additional proxy material May 9, 2025 —
DEFA14A Additional proxy material Apr 30, 2025 —
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 30, 2025 Apr 30, 2025
25-NSE Delisting notice Apr 30, 2025 —
8-K Current report
Auditor change
Apr 25, 2025 Apr 23, 2025
424B3 Prospectus Apr 21, 2025 —
PRE 14A Preliminary proxy statement Apr 18, 2025 Dec 31, 2024
EFFECT Filing Apr 17, 2025 —
8-K Current report
Material agreement
Apr 17, 2025 Apr 17, 2025
424B5 Prospectus supplement Apr 17, 2025 —
EFFECT Filing Apr 15, 2025 —
CORRESP Letter to the SEC Apr 15, 2025 —
UPLOAD Letter from the SEC Apr 14, 2025 —
CORRESP Letter to the SEC Apr 11, 2025 —
8-K Current report
Other events
Apr 11, 2025 Apr 11, 2025
S-3/A Filing Apr 11, 2025 —
S-3/A Filing Apr 10, 2025 —
S-3 Shelf registration Apr 8, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Mar 25, 2025 Mar 25, 2025
10-K Annual report Mar 24, 2025 Dec 31, 2024
3 Initial insider ownership Mar 14, 2025 Feb 21, 2025
8-K Current report
Other events
Mar 10, 2025 Mar 5, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 28, 2025 —
8-K Current report
Unregistered share sale
Feb 21, 2025 Feb 18, 2025
8-K Current report
Other events
Feb 18, 2025 Feb 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
D Filing Feb 7, 2025 —
S-8 Employee stock plan registration Jan 31, 2025 —
S-8 Employee stock plan registration Jan 31, 2025 —
8-K Current report
Listing notice, Unregistered share sale, Change to shareholder rights
Jan 24, 2025 Jan 23, 2025
8-K Current report
Listing notice, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
Jan 21, 2025 Jan 17, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jan 15, 2025 Jan 15, 2025
DEFA14A Additional proxy material Jan 7, 2025 —
UPLOAD Letter from the SEC Dec 26, 2024 —
S-3 Shelf registration Dec 20, 2024 —
144 Notice of proposed sale Dec 12, 2024 —
SC 13D/A Amended ownership over 5% (active) Dec 12, 2024 —
144 Notice of proposed sale Dec 9, 2024 —
144 Notice of proposed sale Dec 6, 2024 —
DEF 14A Proxy statement Dec 6, 2024 Dec 6, 2024
144 Notice of proposed sale Dec 5, 2024 —
8-K Current report
Material agreement, New debt, Change to shareholder rights
Nov 29, 2024 Nov 22, 2024
PRE 14A Preliminary proxy statement Nov 21, 2024 Nov 21, 2024
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights
Nov 21, 2024 Nov 15, 2024
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2024 Nov 14, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
4 Insider transaction Oct 23, 2024 Oct 21, 2024
SC 13G Ownership over 5% (passive) Sep 23, 2024 —
4 Insider transaction Sep 20, 2024 Sep 19, 2024
3 Initial insider ownership Sep 20, 2024 Sep 10, 2024
8-K Current report
Acquisition or sale of assets, Listing notice, Officer or director change, Regulation FD disclosure
Sep 16, 2024 Sep 10, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2024 Aug 13, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Shareholder vote results
Jun 20, 2024 Jun 20, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 14, 2024 May 14, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Material agreement, Change to shareholder rights
May 7, 2024 May 1, 2024
8-K Current report
Regulation FD disclosure
May 1, 2024 Apr 30, 2024
DEFA14A Additional proxy material Apr 29, 2024 —
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 29, 2024 Apr 29, 2024
8-K Current report
Material agreement
Apr 26, 2024 Apr 25, 2024
10-K Annual report Mar 25, 2024 Dec 31, 2023
8-K Current report
Material agreement, Change to shareholder rights
Mar 14, 2024 Mar 13, 2024
8-K Current report
Material agreement, Change to shareholder rights
Mar 14, 2024 Mar 12, 2024
8-K Current report
Listing notice
Mar 8, 2024 Mar 7, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
SC 13D/A Amended ownership over 5% (active) Feb 20, 2024 —
8-K Current report
Acquisition or sale of assets, Change to shareholder rights, Other events
Feb 16, 2024 Feb 15, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
8-K Current report
Other events
Feb 9, 2024 Feb 9, 2024
S-8 Employee stock plan registration Feb 6, 2024 —
S-8 Employee stock plan registration Feb 6, 2024 —
SC 13D/A Amended ownership over 5% (active) Feb 2, 2024 —
4 Insider transaction Jan 30, 2024 Jan 26, 2024
8-K Current report
Other events
Jan 30, 2024 Jan 26, 2024
8-K Current report
Other events
Jan 8, 2024 Jan 5, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Dec 5, 2023 Dec 5, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 15, 2023 Nov 14, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Material agreement, Change to shareholder rights
Oct 18, 2023 Oct 17, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Other events
Jun 28, 2023 Jun 28, 2023
8-K Current report
Shareholder vote results
Jun 21, 2023 Jun 21, 2023
8-K Current report
Unregistered share sale
Jun 6, 2023 May 31, 2023
424B5 Prospectus supplement May 30, 2023 —
10-Q Quarterly report May 15, 2023 Mar 31, 2023
DEF 14A Proxy statement May 1, 2023 May 1, 2023
DEFA14A Additional proxy material May 1, 2023 —
4 Insider transaction May 1, 2023 May 4, 2022
3/A Amended initial statement of beneficial ownership of securities May 1, 2023 Feb 22, 2022
PRE 14A Preliminary proxy statement Apr 19, 2023 Apr 19, 2023
4/A Amended statement of changes in beneficial ownership of securities Apr 13, 2023 Nov 30, 2022
8-K Current report
Regulation FD disclosure
Apr 3, 2023 Mar 31, 2023
8-K Current report
Shareholder vote results
Mar 31, 2023 Mar 31, 2023
8-K Current report
Material agreement, New debt, Change to shareholder rights
Mar 24, 2023 Mar 21, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Mar 15, 2023 Mar 14, 2023
8-K Current report
Material agreement, New debt, Change to shareholder rights
Mar 14, 2023 Mar 13, 2023
10-K Annual report Mar 14, 2023 Dec 31, 2022
8-K Current report
Material agreement, Change to shareholder rights
Mar 13, 2023 Mar 7, 2023
DEF 14A Proxy statement Feb 21, 2023 Feb 21, 2023
8-K Current report
Agreement ended, Other events
Feb 17, 2023 Feb 13, 2023
8-K Current report
Regulation FD disclosure
Feb 16, 2023 Feb 15, 2023
S-8 Employee stock plan registration Feb 10, 2023 —
S-8 Employee stock plan registration Feb 10, 2023 —
PRE 14A Preliminary proxy statement Feb 8, 2023 Feb 8, 2023
4 Insider transaction Feb 2, 2023 Jan 30, 2023
4 Insider transaction Feb 2, 2023 Jan 30, 2023
4 Insider transaction Feb 2, 2023 Jan 30, 2023
4 Insider transaction Feb 2, 2023 Jan 30, 2023
4 Insider transaction Feb 2, 2023 Jan 30, 2023
4 Insider transaction Feb 2, 2023 Jan 30, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
PAVM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1624326
Former names
PAXmed Inc. (until Mar 26, 2015)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.